Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Acute aortic syndromes require a high index of suspicion for early diagnosis and may benefit from personalized treatment approaches based on specific anatomical and patient characteristics.
Although acute aortic dissection was first described as a potentially catastrophic diagnosis more than two centuries ago by Nicholls, its epidemiology, diagnosis and treatment continue to evolve.1 In this special supplement of the European Heart Journal: Acute Cardiovascular Care, a series of important studies illustrate the high stakes related to early diagnosis, emergency care and long-term follow-up of patients with acute aortic dissection. These studies highlight both advances in knowledge but also raise questions as to the optimal way to predict, prevent and treat acute aortic syndromes. The contribution of acute aortic syndromes to the incidence of out-of-hospital cardiac arrest (OHCA) has been underappreciated. However, the broad availability of high quality axial imaging with computed tomography (CT) has led to greater recognition of acute aortic syndromes as a cause of OHCA. Takeuchi et al.2 describe the findings in a single centre series of 1011 patients with OHCA with 934 undergoing CT and found that 7.6% had an acute aortic syndrome, a frequency that is strikingly high. The majority had type A pathology versus type B (66 vs. 5) with mechanisms for arrest including pericardial effusion and massive haemorrhage.2 These findings suggest that acute aortic syndromes play a relevant role in cardiac arrest and underscore the need for greater diagnostic awareness as well as improved prevention. The epidemiology of acute aortic syndromes is further elucidated in a descriptive analysis of 18,348 patients with acute aortic syndrome captured in the Japanese Registry of All Cardiac and Vascular Diseases.3 This large dataset provides novel insight into possible seasonal variations in the incidence of acute aortic syndromes (autumn–winter predominant), and important trends in approaches to management, with a more than two-fold increase in the use of endovascular management of type B dissection. Unfortunately, although outcomes are improving, mortality rates remain high, particularly for type A dissection (24.3%) and most notably for those not treated surgically (49.7%); again underscoring the need for better prevention and early diagnosis and treatment. Early and accurate diagnosis, a key factor in enabling early treatment, remains a clinical challenge. Although imaging remains the gold standard for diagnosis, the need for rapid diagnosis coupled with the relative infrequency and diverse symptoms associated with acute aortic syndromes has led to novel approaches to diagnosis. For example, in a retrospective analysis of 350 patients with acute type A dissection, Zaschke et al.4 demonstrate that early suspicion significantly shorted the median time from pain onset to surgical intervention from a median of 8.6 hours to 5.5 hours. In addition, of those patients initially misdiagnosed, 41% had an aortic dissection detection risk score (ADD-RS) that was 2 or greater and, although applied retrospectively, might have improved time to diagnosis. The use of such risk scores may be augmented with biomarkers that hold promise for greater diagnostic accuracy. A systematic review and meta-analysis by Tsutsumi et al. including 26,598 patients assessed with the ADD-RS and 3421 with D-dimer found a pooled sensitivity of 0.99–1.00 for the combination of ADD-RS of 1 or greater with elevated D-dimer, and a failure rate of 0.1% in a low prevalence population and 0.6% in a high prevalence population.5 These findings led the authors to conclude that this combined approach may be useful but that the thresholds used may depend on the clinical setting. The observation of high associated mortality with type A acute aortic syndromes that are treated conservatively may overly simplify the optimal treatment as there may be heterogeneity in the mortality risk related to anatomical characteristics. Previous series have suggested that type A intramural haematoma and type A dissections with retrograde pathology from an entry in the descending aorta may be associated with lower mortality than other anatomical presentations with type A dissection, and such studies have raised the question as to whether conservative management may be appropriate in these anatomical subsets.6 Sadamatsu et al. evaluated initial conservative management in type A dissection with such anatomy.7 In a series of 131 consecutive patients including 58 with type A dissection and of those who had no contraindications for surgery, 23 were treated with an initial medical therapy and 26 with a surgical approach. Patients selected for surgery had smaller aortic diameters and well treated haemodynamics. Overall mortality rates were not higher in the medically managed group suggesting that careful patient selection might enable the identification of a subgroup that could be treated conservatively. Current recommendations that patients with type A intramural haematoma undergo surgery is based on expert opinion; data such as these may prompt reconsideration of these recommendations. Additional prospective registries are needed to shape future iterations of management guidelines.8 In all patients with diagnosed acute aortic syndromes, management of blood pressure is a key aspect of management and vasodilators are indicated in those with elevated blood pressure after establishing adequate heart rate control. Sodium nitroprusside is frequently used in this setting; however, Alviar et al.9 cite cost as a potential issue impacting access and thus evaluated intravenous clevidipine, a calcium antagonist with favourable pharmacodynamics including rapid onset and short half-life as an alternative. Compared with sodium nitroprusside in a non-randomised retrospective case series of 85 patients with acute aortic syndromes at the Cleveland Clinic, the haemodynamic control found was similar between the groups as was safety, suggesting clevidipine as a cost-saving alternative.9 Collectively, these observations remind us that although long recognised, acute aortic syndromes remain among the most catastrophic cardiovascular events. In fact, the incidence may be meaningfully greater than previously recognised. Early diagnosis is facilitated by a high index of suspicion coupled with the aid of risk scores and biomarkers and is critical for rapid triage and treatment. Although treatment pathways based on the Stanford categories of type A and type B appear straightforward, in reality the varied phenotypes of acute aortic syndromes are far more complex, and tailored treatment accounting for patient and anatomical characteristics may enable a more personalised approach. Regardless of this, the single clearest message from this body of work is that we need more research to understand better how to diagnose and treat this old and feared condition. Approaches to predict and prevent future aortic events should be our ultimate goal in eliminating catastrophic aortic diseases.
No takes yet. Share an insight, caveat, or question.
Bonaca et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: